Importance of cytogenetic markers for multiple primary carcinomas in colorectal cancer: Chromosome 17 and p53 locus translocation

Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 670-677

  Tagawa, Yutaka ^a   Nanashima, Atsushi ^a   Tsuji, Takashi ^a   Sawai, Terumitsu ^a   Yamaguchi, Hiroyuki ^a   Yasutake, Toru ^a   Nakagoe, Tohru ^a   Ayabe, Hiroyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Chromosome 17; Fluorescence in situ hybridization; p53 locus; Translocation multiple primary cancers

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GENETICS; CANCER STAGING; CHROMOSOME 17; CHROMOSOME TRANSLOCATION; COLORECTAL CANCER; COSMID; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; COLORECTAL NEOPLASMS; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS, MULTIPLE PRIMARY; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0031718603     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050154     Document Type: Article

References (46)

1. Lynch HT, Kimberling W, Albano WA, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Cancer 1985;56:934-938.
2. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-5362.
3. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-1038.
4. Jiricny J. Colon cancer and DNA repair: Have mismatches met their match? Trends Genet 1994;10:164-168.
5. Strivastava S, Zou ZQ, Pirollo K, et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:747-749.
6. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familiar syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238.
7. Watanabe S. Epidemiology of multiple primary cancer (in Japanese with English abstract). Gan to Kagaku Ryoho (Jpn J Cancer Chemotherapy) 1990;17:967-973.
8. Anonymous. Clinical and pathological analyses of patients with a family history of colorectal cancer. Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Clin Oncol 1993;23:342-349.
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
10. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletion and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-221.
11. Meling GI, Lothe RA, Borresen AL, et al. The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. Br J Cancer 1993;67:93-98.
12. Matsuyama H, Pan Y, Mahdy EA, et al. p53 Deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res 1994;54:6057-6060.
13. Starzynska T, Bromley M, Ghosh A, et al. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;66:558-562.
14. Rigas B. Oncogenes and suppressor genes: Their involvement in colon cancer. J Clin Gastroenterol 1990;12:494-499.
15. Miller WH, Dmitrovsky E. Oncogenes and clinical oncology. Curr Opin Oncol 1991;3:65-69.
16. Yamaguchi H, Kaneda K, Aya T, et al. Chromosome and DNA analysis of peripheral blood lymphocytes from the quadruple cancer patient. Jpn J Cancer Chemother 1992;19:1055-1057.
17. Zhou JY, Taguchi T, Siegfried JM, et al. Characterization of 9q; 15q whole-arm translocation derivatives in non-small cell lung carcinomas by fluorescence in situ hybridization. Cancer Genet Cytogenet 1993;69:1-6.
18. Van Dyke DL, Worsham MJ, Benninger MS, et al. Recurrent cytogenetic abnormalities m squamous cell carcinomas of the head and neck region. Genes Chrom Cancer 1994;9:192-206.
19. Zhao WP, Gnarra JR, Liu S, et al. Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines. Cancer Genet Cytogenet 1995;82:128-139.
20. Xiao S, Wei W, Feng XL, et al. Direct chromosome analysis of seven primary colorectal carcinomas. Cancer Genet Cytogenet 1992;62:32-39.
21. Pinkel D, Landegent J, Collins C, et al. Fluroescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocation of chromosome 4. Proc Natl Acad Sci USA 1988;85:9138-9142.
22. Matsumura K, Kallioniemi A, Kallioniemi O, et al. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 1992;52:3474-3477.
23. Kallioniemi OP, Kallioniemi A, Kurisu W, et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1992;89:5321-5325.
24. Kobayashi M, Kawashima A, Mai M, et al. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. Am J Pathol 1996;149:1575-1584.
25. Carter NP. Cytogenetic analysis by chromosome painting. Cytometry 1994;18:2-10.
26. Cremer T, Lichter P, Borden J, et al. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Genet 1988;80:235-246.
27. Hammond DW, Hancock BW, Goyns MH. Identification of a subclass of double minute chromosomes containing centromere-associated DNA. Genes Chromosom Cancer 1994;10:139-142.
28. Noguchi P, Wallace J, Johnson E, et al. Characterization of WIDR: A human colon carcinoma cell line. In Vitro 1979;15: 401-408.
29. Sheng WW, Leu SY, Wuu KD. Chromosome analysis on two long-term established human colorectal carcinoma cell lines. Proceedings of the National Science Council, Republic of China-Part B. Life Sci 1991;15:111-116.
30. Trent J, Crickard K, Gibas Z, et al. methodologic advances in the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986;19:57-66.
31. Pandis N, Heim S, Bardi G, et al. Improved technique for short-term culture and cytogenetic analysis of human breast cancer. Genes Chrom Cancer 1992;5:14-20.
32. Tanaka K, Testa JR. Assessment of methods for the cytogenetic analysis of human solid tumors. JNCI 1987;79:1287-1293.
33. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-2938.
34. Muleris M, Salmon R-J, Dutrillaux B. Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet 1990;46:143-156.
35. Xiao S, Wei W, Feng XL, et al. Direct chromosome analysis of seven primary colorectal carcinomas. Cancer Genet Cytogenet 1992;62:32-39.
36. Bardi G, Sukhikh T, Pandis N, et al. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosom Cancer 1995;12:97-109.
37. Nakai H, Misawa S, Tanaka S, et al. p53 Gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Phl)-positive acute leukemia. Leukemia 1993;7:1547-1551.
38. Ookawa K, Sakamoto M, Hirohashi S, et al. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 1993;53:382-387.
39. Guo W, Wang SW, Feng CH. p53 Antioncogene abnormalities in osteosarcoma (in Chinese with English abstract). Chin J Surg 1994;32:412-415.
40. Li HC, Lu SX. Mutation of p53 gene in human cancers of the esophagus and gastric cardia (in Chinese with English abstract). Chin J Oncol 1994;16:172-176.
41. Albertson DG, Fishpoo, R, Sherrington P, et al. Sensitive and high resolution in situ hybridization to human chromosomes using biotin labelled probes: Assignment of the human thymocyte CD1 antigen cenes to chromosome 1. EMBO J 1988;7:2801-2805.
42. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992;102:1136-1141.
43. Bardi G, Johansson B, Pandis N, et al. Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features. Cancer 1993;71:306-314.
44. Tsao SW, Mok CH, Oike K, et al. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Res 1991;11:1975-1982.
45. Levin B, Reichmann A. Chromosomes and large bowel tumors. Cancer Genet Cytogent 1986;19:159-162.
46. Ramaekers F, Hopman A, Vooijs P. Advances in the detection of ploidy differences in cancer by in situ hybridization. Anal Cell Pathol 1992;4:337-344.